TI
RIGL icon

Trexquant Investment’s Rigel Pharmaceuticals RIGL Stock Holding History

Trexquant Investment’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.85M Buy
216,410
+19,262
+10% +$647K 0.04% 579
2025
Q4 		$8.44M Buy
197,148
+30,030
+18% +$1.13M 0.08% 372
2025
Q3 		$4.73M Buy
+167,118
New +$5M 0.05% 570
2025
Q2 		– Sell
-33,101
Closed -$595K – 1818
2025
Q1 		$595K Sell
33,101
-11,070
-25% -$225K 0.01% 1238
2024
Q4 		$743K Buy
+44,171
New +$847K 0.01% 1186

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return